VOYA Investment Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $362K | Buy |
|
|||||
|
2025
Q1 | $319K | Sell |
|
|||||
|
2024
Q4 | $492K | Sell |
|
|||||
|
2024
Q3 | $714K | Sell |
|
|||||
|
2024
Q2 | $796K | Buy |
|
|||||
|
2024
Q1 | $824K | Buy |
|
|||||
|
2023
Q4 | $737K | Sell |
|
|||||
|
2023
Q3 | $512K | Buy |
|
|||||
|
2023
Q2 | $624K | Buy |
|
|||||
|
2023
Q1 | $629K | Sell |
|
|||||
|
2022
Q4 | $786K | Hold |
|
|||||
|
2022
Q3 | $496K | Hold |
|
|||||
|
2022
Q2 | $475K | Sell |
|
|||||
|
2022
Q1 | $612K | Hold |
|
|||||
|
2021
Q4 | $695K | Buy |
|
|||||
|
2021
Q3 | $963K | Buy |
|
|||||
|
2021
Q2 | $516K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $129K | Hold |
|
|||||
|
2017
Q4 | $157K | Buy |
|
|||||
|
2017
Q3 | $145K | Hold |
|
|||||
|
2017
Q2 | $125K | Buy |
|
|||||
|
2017
Q1 | $155K | Hold |
|
|||||
|
2016
Q4 | $152K | Hold |
|
|||||
|
2016
Q3 | $174 | Hold |
|
|||||
|
2016
Q2 | $189K | Hold |
|
|||||
|
2016
Q1 | $163K | Sell |
|
|||||
|
2015
Q4 | $9.54M | Sell |
|
|||||
|
2015
Q3 | $7M | Buy |
|
|||||
|
2015
Q2 | $14.6M | Buy |
|
|||||
|
2015
Q1 | $14.2M | Sell |
|
|||||
|
2014
Q4 | $12.2M | Buy |
|
|||||
|
2014
Q3 | $627K | Hold |
|
|||||
|
2014
Q2 | $790K | Hold |
|
|||||
|
2014
Q1 | $855K | Hold |
|
|||||
|
2013
Q4 | $1.17M | Buy |
|
|||||
|
2013
Q3 | $1.64M | Hold |
|
|||||
|
2013
Q2 | $724K | Buy |
|